1-2 of 2
Silvio Parodi, MD
Close
Sort by
Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Gabriele Zoppoli, MD, Michele Cea, MD, Floriana Fruscione, Santina Bruzzone, Ph.D., Debora Soncini, Davide Bedognetti, MD, Eva Moran, Ph.D., Enrico Balleari, MD, Andrea Bruzzone, MD, Anna Garuti, Gabriella Cirmena, Ilaria Rocco, Marco Gobbi, MD, Ph.D., Riccardo Ghio, MD, Ph.D., Yves Pommier, MD, Ph.D., Angelo Michele Carella, MD, Ph.D., Alberto Ballestrero, MD, Ph.D., Silvio Parodi, MD, Ph.D., Franco Patrone, MD, Ph.D., Alessio Nencioni, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2733.
https://doi.org/10.1182/blood.V114.22.2733.2733
Published: 2009
Journal Articles

Modulated Expression of BCL-xL and GATA-1 Genes Is a Common Feature in Myeloproliferative Disorders (MPD) Both in JAK2-V617F Positive and Negative Patients

Sarah Pozzi, BSC, Francesca Bertolotti, BSC, Silvio Parodi, MD, Raffaella Ponassi, BSC, Barbara Biasotti, BSC, Silvia Bruno, BSC, Vittorio Rosti, MD, Alessia Parodi, BSC, Barbara Bruno, BSC, Davide Imperiale, Giovanna Piaggio, BSC, Marina Podestà€, BSC, Andrea Gallamini, MD, Caterina Passalia, MD, Giovanni Barosi, MD, Francesco Frassoni, MD
Journal: Blood
Blood (2007) 110 (11): 1533.
https://doi.org/10.1182/blood.V110.11.1533.1533
Published: 2007